Edition:
United Kingdom

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

67.20CHF
22 Jun 2018
Change (% chg)

CHF0.50 (+0.75%)
Prev Close
CHF66.70
Open
CHF66.70
Day's High
CHF67.65
Day's Low
CHF66.60
Volume
31,444
Avg. Vol
57,144
52-wk High
CHF87.10
52-wk Low
CHF63.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 49.51 0.111
Jun '17 41.17 -1.899
FY 2016 Dec '16 35.31 -2.308
Jun '16 29.72 -2.759
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 4 115.32 129.50 104.00 94.45
Year Ending Dec-19 4 134.30 155.80 121.09 122.60
Earnings (per share)
Year Ending Dec-18 3 -1.55 -1.11 -2.43 -2.35
Year Ending Dec-19 3 -0.64 0.81 -1.53 -0.61
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 82.81 32.74
P/E High - Last 5 Yrs. -- 289.15 45.73
P/E Low - Last 5 Yrs. -- 90.24 24.23
Beta 1.31 0.91 0.88
Price to Sales (TTM) 12.39 109.18 5.71
Price to Book (MRQ) -- 13.44 5.37
Price to Tangible Book (MRQ) -- 13.96 6.94
Price to Cash Flow (TTM) -- 70.39 23.32
% Owned Institutions -- 13.84 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.50
Dividend Yield - 5 Year Avg 1.21 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) -- 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 38.49 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago 35.14 77.35 5.68
Sales - 5 Yr. Growth Rate -0.50 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.18 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago 28.13 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate -34.31 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.78 1.83 2.19
Current Ratio (MRQ) 2.98 5.26 2.98
LT Debt to Equity (MRQ) -- 24.54 12.19
Total Debt to Equity (MRQ) -- 26.17 16.46
Interest Coverage (TTM) -17.38 -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.31 40.81 54.46
Gross Margin - 5 Yr. Avg. -- 51.76 52.22
EBITD Margin (TTM) -45.22 -- --
EBITD - 5 Yr. Avg -84.28 -564.12 10.98
Operating Margin (TTM) -48.03 -706.11 4.74
Operating Margin - 5 Yr. Avg. -89.66 -585.15 6.41
Pre-Tax Margin (TTM) -56.97 -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -92.75 -588.45 6.83
Net Profit Margin (TTM) -57.44 -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -93.21 -591.46 3.10
Effective Tax Rate (TTM) -- 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 318,667 22,312,275 846,855,748
Net Income/Employee (TTM) -183,042 2,947,385 99,619,396
Receivable Turnover (TTM) 27.34 19.92 5.78
Inventory Turnover (TTM) 0.45 2.37 3.35
Asset Turnover (TTM) 0.24 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.74 -0.70 10.95
Return on Assets - 5 Yr. Avg. -14.90 -0.06 12.32
Return on Investment (TTM) -17.70 2.00 14.38
Return on Investment - 5 Yr. Avg. -18.35 2.81 16.11
Return on Equity (TTM) -- 3.49 16.08
Return on Equity - 5 Yr. Avg. -78.01 4.33 17.41
  1 Year 3 Year 5 Year
Sales % 25.91 16.67 -0.50
EPS (TTM) % 16.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -4.81 99 53
13 Week -1.24 -5.17 99 69
26 Week -5.55 -11.79 99 77
52 Week 5.61 -6.73 99 48
YTD 9.37 -2.83 99 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 30.46%
# of Holders: 74
Total Shares Held: 3,617,721
3 Mo. Net Change: 18,541
# New Positions: 2
# Closed Positions: 5
# Increased Positions: 18
# Reduced Positions: 13
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.